# FDA recall D-840-2013

> **AstraZeneca Pharmaceuticals LP** · Class II · drug recall initiated 2013-06-21.

## Product

MERREM I.V. (meropenem for injection), 1 g meropenem equivalent, 30 mL vial, Rx only, Mfd for: AstraZeneca Pharmaceuticals LP, Wilmington, DE by ACS Dobfar SpA Viale Addetta, Tribiano, Milano Italy NDC  0310 0321 30

## Reason for recall

Presence of Precipitate; potential for incomplete constitution upon addition of diluent.

## Distribution

USA and Puerto Rico

## Key facts

- **Recall number:** D-840-2013
- **Recalling firm:** AstraZeneca Pharmaceuticals LP
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-06-21
- **Report date:** 2013-08-14
- **Termination date:** 2015-01-29

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Wilmington, DE, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-840-2013

## Citation

> AI Analytics. FDA recall D-840-2013. Retrieved 2026-05-28 from https://api.ai-analytics.org/recall/D-840-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*